Home  > 
  OncoSec reports positive phase II data of ImmunoPulse IL-12 in combo with pembrolizumab in anti-PD-1 non-responder melanoma patients,   February 25, 2017
  Inovio presents positive clinical data on vaccine advances in fight against emerging infectious diseases,   February 25, 2017
  GSK, Innoviva announce positive results from Relvar Ellipta lung function study in patients with well-controlled asthma,   February 24, 2017
  Takeda, Cognition Kit collaborate to study the use of wearable software in patients with MDD,   February 24, 2017
  NIH initiates clinical trial of investigational vaccine against respiratory syncytial virus,   February 24, 2017
  PfSPZ malaria vaccine provides durable protection against multiple strains in NIH trial,   February 23, 2017
  Zydus Cadila receives US FDA approval to begin phase II trial of saroglitazar magnesium in patients with PBC,   February 23, 2017
  NIH-supported trials of testosterone therapy in older men report mixed results,   February 23, 2017
  NIAID initiates clinical trial of investigational vaccine to protect against mosquito-borne diseases,   February 22, 2017
  Lanthio Pharma begins phase 1 clinical study with MOR107,   February 22, 2017
  Ergomed's partner Modus raises £ 2.9 mn for clinical development of sevuparin to treat sickle cell disease,   February 21, 2017
  Clintec marks 20th year of global clinical research with launch of new brand,   February 21, 2017
  ArQule and Daiichi Sankyo's METIV-HCC phase 3 study of tivantinib in HCC fails to meet primary endpoint,   February 21, 2017
  Nektar presents positive data from phase 1 study of its immuno-oncology agent, NKTR-214 in patients with RCC at ASCO GU 2017,   February 20, 2017
  Pfizer in partnership with Celltrion presents new data for Inflectra in Crohn’s disease,   February 20, 2017
  AstraZeneca presents positive results from phase I/II trial of durvalumab in patients with urothelial cancer at ASCO Genitourinary Cancers Symposium,   February 20, 2017
  Takeda, TiGenix announce phase 3 study shows Cx601 maintained long-term remission of complex perianal fistulas in Crohn's disease,   February 20, 2017
  AstraZeneca's Lynparza meets primary endpoint in phase III study in BRCA-mutated metastatic breast cancer,   February 20, 2017
  Pixium Vision announces first implantation and activation of IRIS II in Spain,   February 18, 2017
  Denovo Biopharma to begin phase 3 study of DB102 as first line therapy for diffuse large B-cell lymphoma,   February 18, 2017

Pharma Project Management 2017
Copyright © 2016 Saffron Media Pvt. Ltd |